Skip to main content

Market Overview

Microsoft Adds New Vaccine Management Tools To Amend Past Loopholes: Bloomberg


Microsoft Corp (NASDAQ: MSFT) launched a new technology to drive government and health care organizations’ vaccine management systems to fix the company’s initial custom-built program deficiencies, Bloomberg reports.

  • The Microsoft Vaccine Management product features and new apps aim to improve and fix the glitches during the Vaccination Registration and Application System in New Jersey and Washington D.C.
  • It used health care standards for quicker data export to electronic medical records. The software also addressed other issues, including user pre-registration before the COVID-19 vaccine appointment and proactive handling of demand spikes.
  • Salesforce.Com Inc (NYSE: CRM) tried to exploit the opportunity by providing a free replacement for Microsoft vaccine cloud software based on their tweet to government officials.
  • Last month, Microsoft faced three consecutive days of problems with the District of Columbia’s online vaccination registration due to a demand spike leading to a public uproar. The vaccine registration resumed on a smoother note from the following week after Microsoft’s admittance of its shortcomings and assurance towards a resolution.
  • New Jersey Governor Phil Murphy criticized significant glitches in the state’s Microsoft-built vaccination scheduling system. Iowa backed out of Microsoft’s contract within a week of its announcement.
  • Price action: MSFT shares traded higher by 0.36% at $231.55 on the last check Friday.

Related Articles (MSFT)

View Comments and Join the Discussion!

Posted-In: Bloomberg COVID-19 VaccineNews Tech Media

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at